Evidence map›Paper›PMID 10196315›Full record

ArticleJournal of virology1999

Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein.

J zu Putlitz, R E Lanford, R I Carlson, L Notvall, S M de la Monte, J R Wands

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

J zu PutlitzMolecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02129, USA.
R E Lanford
R I Carlson
L Notvall
S M de la Monte
J R Wands
Harvard University · USTexas Biomedical Research Institute · USMassachusetts General Hospital · US

Funding

PATHOGENESIS, IMMUNODIAGNOSIS AND THERAPY OF HCCR37CA035711 · NCI · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 2000 to 2008
$2.9M
PATHOGENESIS, IMMUNODIAGNOSIS, AND THERAPY OF HCCR01CA035711 · NCI · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 1985 to 1999
–
NCI NIH HHS CA-35711NCI NIH HHS R01 CA035711NCI NIH HHS R37 CA035711NIAAA NIH HHS AA-02169
6 · The paper itself

Abstract

Hepadnavirus polymerases are multifunctional enzymes that play critical roles during the viral life cycle but have been difficult to study due to a lack of a well-defined panel of monoclonal antibodies (MAbs). We have used recombinant human hepatitis B virus (HBV) polymerase (Pol) expressed in and purified from baculovirus-infected insect cells to generate a panel of six MAbs directed against HBV Pol protein. Such MAbs were subsequently characterized with respect to their isotypes and functions in analytical and preparative assays. Using these MAbs as probes together with various deletion mutants of Pol expressed in insect cells, we mapped the B-cell epitopes of Pol recognized by these MAbs to amino acids (aa) 8 to 20 and 20 to 30 in the terminal protein (TP) region of Pol, to aa 225 to 250 in the spacer region, and to aa 800 to 832 in the RNase H domain. Confocal microscopy and immunocytochemical studies using various Pol-specific MAbs revealed that the protein itself appears to be exclusively localized to the cytoplasm. Finally, MAbs specific for the TP domain, but not MAbs specific for the spacer or RNase H regions of Pol, appeared to inhibit Pol function in the in vitro priming assay, suggesting that antibody-mediated interference with TP may now be assessed in the context of HBV replication.

Indexed as

AnimalsAntibodies, MonoclonalBlotting, WesternCell LineEpitope MappingFluorescent Antibody Technique, IndirectGene Products, polHepatitis B AntibodiesHepatitis B virusHumansMiceMice, Inbred BALB CPrecipitin TestsRNA-Directed DNA PolymeraseTumor Cells, CulturedAntibodies, MonoclonalGene Products, polHepatitis B AntibodiesP protein, Hepatitis B virusRNA-Directed DNA Polymerase

Identifiers

PMID10196315
PMCPMC104198
OpenAlexW1501861737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.